CD8A and small cell lung carcinoma: CD8 T cells in malignant tumors have been associated with better survival in breast cancer (BC), small cell lung carcinoma (SCLC), carcinomas of colon, bile duct, urothelium, and esophagus, as well as follicular lymphoma and uveal melanoma (4–11).